**Abstract**

**Objective**: Clozapine is a potent antipsychotics agent commonly prescribed for patients with refractory schizophrenia. However, it is also related to many troublesome adverse effects. For example, the common genitourinary adverse effects such as enuresis and urinary incontinence. Although clozapine is known for high anticholinergic activity, there has been only one case report about clozapine-related urinary retention in the literature. The aim of this study is to report a case of with clozapine-induced urinary retention and to discuss potential mechanisms.

**Methods**: Case report.

**Results:** We report a 19-year-old male patient of refractory schizophrenia who developed acute urinary retention during treatment with clozapine 200 mg/day and haloperidol 10 mg/day. Urodynamic study suggested dysfunctional voiding. After a series of work-up, simplification of medications and dose adjustment, the urinary retention seemed to be resulted from clozapine. The total score of Adverse Drug Reaction Probability Scale is 7. The urinary retention didn't respond to bethanechol (a cholinergic agent) and tamsulosin (a selective α1 receptor antagonist), and it resolved completely after discontinuation of clozapine while haloperidol 10 mg/day was kept.

**Discussion and conclusions**: Anticholinergic effect of clozapine has been suspected to contribute to impaired detrusor muscle contraction and therefore urinary retention, however, the urodynamic study in the case reported showed normal detrusor function during filling and voiding. Treatment with cholinergic agent didn't improve urinary retention as well. This case report highlights that urinary retention can be an uncommon adverse effect of clozapine and may not be merely resulted from anticholinergic effect.
